The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Status:
Unknown status
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The investigators' Hypothesis is that "The correct timing of gametocytocidal drug in
combination with an effective Artemisinin Combination Therapy can limit the infectiousness of
malaria-infected individuals to less than one week after initiation of treatment"
Phase:
Phase 4
Details
Lead Sponsor:
Kilimanjaro Clinical Research Institute
Collaborators:
Ifakara Health Institute London School of Hygiene and Tropical Medicine